SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001171843-11-001675
Filing Date
2011-05-31
Accepted
2011-05-31 15:49:45
Documents
16
Period of Report
2010-11-30

Document Format Files

Seq Description Document Type Size
1 FORM 20-F f20f_053111.htm 20-F 2611646
2 EXHIBIT 4.51 exh_451.htm EX-4 341268
3 EXHIBIT 4.52 exh_452.htm EX-4 160433
4 EXHIBIT 4.53 exh_453.htm EX-4 116118
5 EXHIBIT 8.1 exh_81.htm EX-8 2681
6 EXHIBIT 12.1 exh_121.htm EX-12 10327
7 EXHIBIT 12.2 exh_122.htm EX-12 10193
8 EXHIBIT 13.1 exh_131.htm EX-13 6533
9 EXHIBIT 13.2 exh_132.htm EX-13 6681
10 EXHIBIT 15.1 exh_151.htm EX-15 8448
11 p35.gif GRAPHIC 7149
12 exh81.jpg GRAPHIC 19876
13 madhani.gif GRAPHIC 3500
14 odidi.gif GRAPHIC 2673
15 deloitte.gif GRAPHIC 1719
16 deloitte_footer.gif GRAPHIC 1449
  Complete submission text file 0001171843-11-001675.txt   3326237
Mailing Address 30 WORCESTER ROAD TORONTO A6 M9W 5X2
Business Address 30 WORCESTER ROAD TORONTO A6 M9W 5X2 416-798-3001
Intellipharmaceutics International Inc. (Filer) CIK: 0001474835 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1130
Type: 20-F | Act: 34 | File No.: 000-53805 | Film No.: 11881327
SIC: 2834 Pharmaceutical Preparations